# VENICE Study Nevirapine Full Dose/Dose Escalation

> **NCT00704249** · PHASE4 · COMPLETED · sponsor: **Clinical Trial Agency of HIV Study Group** · enrollment: 80 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** nevirapine
- **DRUG:** nevirapine

## Key facts

- **NCT ID:** NCT00704249
- **Lead sponsor:** Clinical Trial Agency of HIV Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-07
- **Final completion:** 2009-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2009-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704249, "VENICE Study Nevirapine Full Dose/Dose Escalation". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00704249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*